Johnson & Johnson shares tumbled Tuesday to lead S&P 500 decliners after the health care giant failed to reach a settlement ...
A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby powder caused cancer.
One big reason the Dow Jones Industrial Average slipped Tuesday had little to do with tariffs. Johnson & Johnson's stock ...
Johnson & Johnson (JNJ) closed the latest trading day at $155.36, indicating a +1.38% change from the previous session's end. The stock's change was more than the S&P 500's daily gain of 0.67%. On the ...
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
Johnson & Johnson announced it has completed its acquisition of Intra-Cellular Therapies. Intra-Cellular Therapies is now part of Johnson ...
Shares of Goldman Sachs and Johnson & Johnson are seeing positive growth Wednesday morning, sending the Dow Jones Industrial Average into positive territory. The Dow was most recently trading 123 ...
A bankruptcy judge in Texas rejected a proposal that would have ended most lawsuits saying the products cause ovarian cancer.